Mingyang Song
Appearances
- DateMay 8, 2023BACKGROUND: Marine omega-3 fatty acids (MO3FAs) - which include eicosapentaenoic acid (EPA), docosapentaenoic acid (DPA), and docosahexaenoic acid (DHA) - are fatty acids that have anti-inflammatory properties, reducing C-reactive protein (CRP) and proinflammatory cytokines…
Presenter
Speakers
Massachusetts General Hospital - DateMay 8, 2023BACKGROUND: Aspirin has been known for its chemopreventive effect against various cancers. Evidence for the chemopreventive effect of the very long-term use of aspirin is still uncertain…
Presenter
Speakers
- DateMay 9, 2023BACKGROUND AND AIMS: Chemoresistance is a major cause of colorectal cancer (CRC) recurrence and death. The critical role of gut microbiome in the efficacy of CRC chemotherapy remains unclear…
Presenter
Speakers
Massachusetts General HospitalMassachusetts General Hospital - DateMay 9, 2023We and others have demonstrated a tight coupling between dietary intake, gut microbial ecology, and near-term alterations in cardiometabolic biomarkers in the ZOE PREDICT-1 study (Zeevi 2015; Asnicar & Berry 2021)…
Presenter
Speakers
- DateMay 8, 2023BACKGROUND: Through shotgun metagenomic sequencing, we identified the depletion of probiotic species_ Lactobacillus acidophilus_ in stools of mice with non-alcoholic fatty liver disease-associated hepatocellular carcinoma (NAFLD-HCC)…
Presenter
Speakers
Massachusetts General HospitalHarborview Medical CenterMassachusetts General Hospital - DateMay 6, 2023Colonoscopy surveillance intervals are based on the predicted risk of metachronous colorectal cancer (CRC) after polyp removal. Due to the presence of co-existent findings at baseline colonoscopy, risk estimation per specific polyp subtype is difficult…
Presenter
Speakers
- DateMay 9, 2023BACKGROUND: Diets high in animal fat and low in plant fiber increase colorectal cancer (CRC) risk, while diets high in fiber, but low in animal fat, are protective. Bacteria present in the colon produce beneficial and harmful metabolites from our diets…
- DateMay 19, 2024BACKGROUND: Post-colonoscopy colorectal cancer (PCCRC), defined as cancer diagnosed after a colonoscopy in which no cancer is found, offers unique insight into our current screening and surveillance practices and how these may need to be adjusted to account for specific patient characteristics and…
Presenter
- DateMay 19, 2024BACKGROUND Growing evidence links high ultra-processed food (UPF) intake to various diseases, including colorectal cancer (CRC). However, the metabolomic changes underlying this relationship remain unknown…
Presenter
- DateMay 20, 2024BACKGROUND: Primary bile acids (PBA) and their gut microbial metabolites (secondary BA [SBA]) modulate immune function and can contribute to intestinal inflammation and tumorigenesis. Diet alters the production and metabolism of BAs…
Presenter
Speakers
Massachusetts General HospitalMassachusetts General Hospital - DateMay 20, 2024BACKGROUND: The long-term risk of colorectal cancer (CRC) incidence and mortality after negative colonoscopy screening (NCS) according to individuals’ risk profiles remains unknown…
Speakers
Massachusetts General HospitalPresenter
- DateMay 21, 2024BACKGROUND: Diet and the gut microbiome are both established modulators of inflammation. However, their combined effect in shaping systemic inflammation remains unknown…
Presenter
Speakers
Massachusetts General Hospital - DateMay 21, 2024BACKGROUND: The gut microbiome is increasingly recognized as an important factor modulating intestinal inflammation, tumorigenesis, and immunological functions…
Presenter
Speakers
Massachusetts General Hospital